CSIMarket
 
Butterfly Network Inc   (NYSE: BFLY)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Butterfly Network Inc's Customers Performance

BFLY



 
BFLY's Source of Revenues During the corresponding time, Butterfly Network Inc recorded a revenue increase by 42.47 % year on year, sequentially revenue grew by 24.07 %. While revenue at the Butterfly Network Inc 's corporate clients

List of BFLY Customers




for the same period Butterfly Network Inc recorded revenue increase by 42.47 % year on year, sequentially revenue grew by 24.07 %.

List of BFLY Customers

Butterfly Network Inc's Business Units
Hardware    44.93 % of total Revenue
Software and other services    36.42 % of total Revenue
Reportable segment    81.35 % of total Revenue
United States    65.51 % of total Revenue
International    15.84 % of total Revenue






Butterfly Network Inc's Comment on Sales, Marketing and Customers



The company provides services to healthcare practitioners worldwide, including approximately 10 million medical doctors, 30 million nurses and midwives, and 2 million veterinarians and veterinary technicians. Its market segments include medical schools for curriculum use, healthcare systems employing doctors and nurses, and a veterinary market focused on companion animal, mixed animal, equine veterinarians, and veterinary academic institutions. The company targets traditional point-of-care ultrasound markets and home care services for conditions such as congestive heart failure, peripheral artery disease, and neurogenic bladder in long-term care facilities. It plans to expand into hospital segments and alternative or home care settings, utilizing its Butterfly iQ3 device and Compass AI™ enterprise software. The addressable market includes over 40 million healthcare practitioners and exceeds $100 billion, with future expansion into wearable, implantable, and interventional markets.


  News about Butterfly Network Inc Contracts

Butterfly Network Aims to Soar at Oppenheimer Conference Amid Market Headwinds,

Butterfly Network Set to Showcase Innovations at Oppenheimer Healthcare Conference Amid Market Challenges Butterfly Network Inc. (NYSE: BFLY) has announced its participation in the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference, scheduled for March 18, 2025. As investors and analysts gear up for the event, the company remains a focal point in the MedTech sector, particularly for its innovative ultrasound imaging technology.As of the latest market data, Butterfly Network shares are trading at $2.85. In a notable performance benchmark, the company’s shares have demonstrated resilience during a challenging market month, recording a -1.78% decline compared to a broader market contex...

Breaking Barriers in Medical Imaging Butterfly Network’s iQ3 Wins Prestigious Award and Expands Globally...

In a groundbreaking moment for medical technology, Butterfly Network’s iQ3 has been recognized as the Best Medical Technology at the 2024 Prix Galien USA Awards. This accolade establishes Butterfly Network, Inc. (NYSE: BFLY), as a frontrunner in the healthcare industry, highlighting its transformative capabilities through portable, semiconductor-based ultrasound technology complemented by intuitive software. Setting a New Standard in Medical Imaging The recognition at the prestigious Prix Galien USA Awards underscores the significant impact Butterfly iQ3 is making in the realm of medical imaging. This third-generation handheld device integrates cutting-edge semiconductor technology, providing a robust and ...




Butterfly Network Inc’s Comment on Sales, Marketing and Customers


The company provides services to healthcare practitioners worldwide, including approximately 10 million medical doctors, 30 million nurses and midwives, and 2 million veterinarians and veterinary technicians. Its market segments include medical schools for curriculum use, healthcare systems employing doctors and nurses, and a veterinary market focused on companion animal, mixed animal, equine veterinarians, and veterinary academic institutions. The company targets traditional point-of-care ultrasound markets and home care services for conditions such as congestive heart failure, peripheral artery disease, and neurogenic bladder in long-term care facilities. It plans to expand into hospital segments and alternative or home care settings, utilizing its Butterfly iQ3 device and Compass AI™ enterprise software. The addressable market includes over 40 million healthcare practitioners and exceeds $100 billion, with future expansion into wearable, implantable, and interventional markets.








BFLY's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Butterfly Network Inc 1,952.65 102.64 -75.77 220
SUBTOTAL 0.00 0.00 0.00 -

Sources: Butterfly Network Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Butterfly Network Inc’s corporate clients.
For your research, we’ve provided 9 tables on Butterfly Network Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.